Role of recombinational repair in sensitivity to an antitumour agent that inhibits bacteriophage T4 type II DNA topoisomerase
- 1 June 1996
- journal article
- Published by Wiley in Molecular Microbiology
- Vol. 20 (6) , 1145-1154
- https://doi.org/10.1111/j.1365-2958.1996.tb02635.x
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Disruption of a topoisomerase-DNA cleavage complex by a DNA helicase.Proceedings of the National Academy of Sciences, 1994
- Localization of an aminoacridine antitumor agent in a type II topoisomerase-DNA complex.Proceedings of the National Academy of Sciences, 1994
- DNA Topoisomerases: Essential Enzymes and Lethal TargetsAnnual Review of Pharmacology and Toxicology, 1994
- DNA topoisomerase-trapping antitumour drugsEuropean Journal Of Cancer, 1992
- UvsY protein of bacteriophage T4 is an accessory protein for in vitro catalysis of strand exchangeJournal of Molecular Biology, 1989
- Bacteriophage T4 DNA topoisomerase is the target of antitumor agent 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA) in T4-infected Escherichia coli.Proceedings of the National Academy of Sciences, 1989
- DNA topoisomerase II: A primer on the enzyme and its unique role as a multidrug target in cancer chemotherapyPharmacology & Therapeutics, 1987
- Nucleotide sequence of a type II DNA topoisomerase gene. Bacteriophage T4 gene 39Nucleic Acids Research, 1986
- Deoxyribonucleic acid repair in bacteriophage.Microbiological Reviews, 1981
- Nalidixic acid resistance: A second genetic character involved in DNA gyrase activityProceedings of the National Academy of Sciences, 1977